Home >Participating Cliinical Centers >The Mayo Clinic College of Medicine

|
The Mayo Clinic College of Medicine |
Contact Information:
Stephen R. Ytterberg, MD
Associate Professor of Medicine
Division of Rheumatology
Mayo Clinic College of Medicine
200 First ST. S.W.
Rochester, MN 55905
E-mail: Ytterberg.Steven@mayo.edu
Tel: 507-284-1625
Ulrich Specks, M.D.
Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Mayo Clinic College of Medicine
200 First ST. S.W.
Rochester, MN 55905
E-mail: specks.ulrich@mayo.edu
Tel: 507-284-2301
Fax: 507-284-4521
Kathy Mieras
Lead Study Coordinator/Project Manager
E-mail: Mieras.kathleen@mayo.edu
Phone: 507-284-9187
Jane Jaquith
Study Coordinator
E-mail: jaquith.jane@mayo.edu
Phone: 507-284-4502
About Us:
The Mayo Clinic Vasculitis Center has an international reputation for the care of patients with vasculitis and research into these diseases. The Mayo Clinic Vasculitis Center has led or participated in all of the major U.S.-based multicentered clinical trials in vasculitis in the past ten years. Dr. Eric Matteson and Dr. Ulrich Specks are Directors of the Mayo Clinic Vasculitis Program.
Current Studies:
5502: Longitudinal Protocol for Giant Cell Arteritis
5503: Longitudinal Protocol for Takayasu's Arteritis
5504: Longitudinal Protocol for Polyarteritis Nodosa
5505: Longitudinal Protocol for Wegener's Granulomatosis and Microscopic Polyangiitis
5506: Longitudinal Protocol for Churg-Strauss Syndrome
5515: VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large-Vessel Vasculitis (Takayasu's Arteritis): Development as Clinical Trial Outcome Measures
5522: VCRC Multi-Center, Open-Label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener’s Granulomatosis (WG)
5523: Concurrent Pilot Studies in Giant Cell Arteritis and Takayasu’s Arteritis to Examine the Safety, Efficacy, and Immunologic Effects of Abatacept (CTLA4-Ig) in Large Vessel Vasculitis (AGATA)
Useful Links:
Mayo Clinic College of Medicine
|